Published in
BioMed Central, Israel Journal of Health Policy Research, 1(7), 2018
DOI: 10.1186/s13584-018-0258-4
Links
Tools
Should we use Palivizumab immunoprophylaxis for infants against respiratory syncytial virus? – a cost-utility analysis
This paper is made freely available by the publisher.
Full text: Download
Data provided by 